PD's second-quarter fiscal 2025 results benefit from an expanding customer base. However, weak top-line guidance negatively impacts share price.

HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.

HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.

Academy Sports' second-quarter fiscal 2024 results reflect soft demand trends due to macroeconomic uncertainties.

Ollie's Bargain's second-quarter fiscal 2024 earnings results reflect comparable store sales growth of 5.8%.

LULU Q2 results reflect soft sales trends on continued weakness in the Americas, wherein comps dipped 3%. Its expense control aids EPS.

VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...

VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.